Immunosuppression by 5-fluorouracil.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000276:immunology*; D000328:Adult; D000368:Aged; D000917:Antibody Formation / Q000187:drug effects*; D000941:Antigens; D001770:Blood Bactericidal Activity; D001792:Blood Platelets / Q000032:analysis; D003110:Colonic Neoplasms / Q000276:immunology; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D006968:Hypersensitivity, Delayed; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007275:Injections, Intravenous; D007958:Leukocyte Count; D008175:Lung Neoplasms / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000276:immunology; D012509:Sarcoma / Q000188:drug therapy / Q000276:immunology*; D012882:Skin Tests; D013045:Species Specificity; D013274:Stomach Neoplasms / Q000276:immunology; D001749:Urinary Bladder Neoplasms / Q000276:immunology
D000941:Antigens; D007166:Immunosuppressive Agents; D005472:Fluorouracil